Skip to main content
. 2016 Feb 15;7(12):14727–14741. doi: 10.18632/oncotarget.7409

Figure 7. Trastuzumab-conjugated mesoporous silica nanoconstruct.

Figure 7

A. TEM image of the mesoporous silica nanoparticle (MSNP) core (scale bar = 50 nm). B. Schematic of surface modification of MSNP (layer-by-layer) with cross-linked polyethylenimine (PEI), polyethyleneglycol (PEG), trastuzumab, and siRNA. C. Hydrodynamic size distribution of T-NP (blue line) and with siRNA loading (black line).